{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:15:09Z","timestamp":1778879709499,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","award":["RF_62097"],"award-info":[{"award-number":["RF_62097"]}],"id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Laboratory Medicine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.plabm.2024.e00410","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T18:39:10Z","timestamp":1716662350000},"page":"e00410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Genetic study of the CDKN2A and CDKN2B genes in renal cell carcinoma patients"],"prefix":"10.1016","volume":"40","author":[{"given":"Nattaradee","family":"Kiatprungvech","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Premsant","family":"Sangkum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rozita","family":"Malinee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchada","family":"Sommaluan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerawat","family":"Korkiatsakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchin","family":"Worawichawong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Budsaba","family":"Rerkamnuaychoke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adcharee","family":"Kongruang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suraida","family":"Aeesoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panuwat","family":"Lertsithichai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kittinut","family":"Kijvikai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wisoot","family":"Kongchareonsombat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5610-4306","authenticated-orcid":false,"given":"Teerapong","family":"Siriboonpiputtana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.plabm.2024.e00410_bib1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJM199609193351207","article-title":"Renal-cell carcinoma","volume":"335","author":"Motzer","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.plabm.2024.e00410_bib2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.drudis.2021.07.009","article-title":"Renal cell carcinoma therapy: current and new drug candidates","volume":"27","author":"Pontes","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.plabm.2024.e00410_bib3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1464-410X.2008.07451.x","article-title":"The changing pattern of kidney cancer incidence and mortality in Europe","volume":"101","author":"Levi","year":"2008","journal-title":"BJU Int."},{"issue":"1","key":"10.1016\/j.plabm.2024.e00410_bib4","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.plabm.2024.e00410_bib5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ccell.2016.03.021","article-title":"SnapShot: renal cell carcinoma","volume":"29","author":"Ricketts","year":"2016","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.plabm.2024.e00410_bib6","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.cell.2015.11.026","article-title":"SnapShot: renal cell carcinoma","volume":"163","author":"Turajlic","year":"2015","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.plabm.2024.e00410_bib7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1590\/0100-3984.2013.1927","article-title":"Renal cell carcinoma: histological classification and correlation with imaging findings","volume":"48","author":"Muglia","year":"2015","journal-title":"Radiol. Bras."},{"issue":"1","key":"10.1016\/j.plabm.2024.e00410_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eururo.2014.04.029","article-title":"Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity","volume":"67","author":"Shuch","year":"2015","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.plabm.2024.e00410_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrc3844","article-title":"VHL, the story of a tumour suppressor gene","volume":"15","author":"Gossage","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.plabm.2024.e00410_bib10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2174\/1566524043359674","article-title":"Hereditary papillary renal carcinoma type I","volume":"4","author":"Dharmawardana","year":"2004","journal-title":"Curr. Mol. Med."},{"issue":"14","key":"10.1016\/j.plabm.2024.e00410_bib11","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.2013.2243","article-title":"Birt-Hogg-Dube syndrome","volume":"309","author":"Perdeaux","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.plabm.2024.e00410_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.juro.2012.07.139","article-title":"Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer","volume":"189","author":"Shuch","year":"2013","journal-title":"J. Urol."},{"issue":"9869","key":"10.1016\/j.plabm.2024.e00410_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(12)61954-0","article-title":"Everolimus for renal angiomyolipoma in tuberous sclerosis","volume":"381","author":"Sooriakumaran","year":"2013","journal-title":"Lancet"},{"issue":"10021","key":"10.1016\/j.plabm.2024.e00410_bib14","first-page":"894","volume":"387","author":"Capitanio","year":"2016","journal-title":"Renal cancer. Lancet."},{"issue":"4","key":"10.1016\/j.plabm.2024.e00410_bib15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/PPO.0b013e3182a102d1","article-title":"PBRM1 and BAP1 as novel targets for renal cell carcinoma","volume":"19","author":"Brugarolas","year":"2013","journal-title":"Cancer J."},{"issue":"4","key":"10.1016\/j.plabm.2024.e00410_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.eururo.2021.12.010","article-title":"Genomics of clear-cell renal cell carcinoma: a systematic review and meta-analysis","volume":"81","author":"Bui","year":"2022","journal-title":"Eur. Urol."},{"issue":"7456","key":"10.1016\/j.plabm.2024.e00410_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature12222","article-title":"Comprehensive molecular characterization of clear cell renal cell carcinoma","volume":"499","author":"Cancer Genome Atlas Research","year":"2013","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.plabm.2024.e00410_bib18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4161\/epi.24552","article-title":"Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC","volume":"8","author":"Ibragimova","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.plabm.2024.e00410_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103287","article-title":"Comprehensive review of chromophobe renal cell carcinoma","volume":"160","author":"Garje","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"14","key":"10.1016\/j.plabm.2024.e00410_bib20","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1158\/1078-0432.CCR-21-0575","article-title":"CDKN2A alterations and response to immunotherapy in solid tumors","volume":"27","author":"Adib","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.plabm.2024.e00410_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ebiom.2016.04.017","article-title":"Implications of genetic and epigenetic alterations of CDKN2A (p16(INK4a)) in cancer","volume":"8","author":"Zhao","year":"2016","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.plabm.2024.e00410_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230306","article-title":"Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations","volume":"15","author":"DeLeon","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.plabm.2024.e00410_bib23","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/s41467-020-14987-6","article-title":"Cancer immune control needs senescence induction by interferon-dependent cell cycle regulator pathways in tumours","volume":"11","author":"Brenner","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.plabm.2024.e00410_bib24","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/s41591-020-0839-y","article-title":"Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma","volume":"26","author":"Braun","year":"2020","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.plabm.2024.e00410_bib25","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/jnci\/djx271","article-title":"Tumor CDKN2A-associated JAK2 loss and susceptibility to immunotherapy resistance","volume":"110","author":"Horn","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.plabm.2024.e00410_bib26","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1158\/2159-8290.CD-14-1096","article-title":"Germline mutations in the CDKN2B tumor suppressor gene predispose to renal cell carcinoma","volume":"5","author":"Jafri","year":"2015","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.plabm.2024.e00410_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/s41379-020-00667-9","article-title":"Adverse histology, homozygous loss of CDKN2A\/B, and complex genomic alterations in locally advanced\/metastatic renal mucinous tubular and spindle cell carcinoma","volume":"34","author":"Yang","year":"2021","journal-title":"Mod. Pathol."},{"issue":"9","key":"10.1016\/j.plabm.2024.e00410_bib28","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/jamaoncol.2018.1986","article-title":"Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma","volume":"4","author":"Carlo","year":"2018","journal-title":"JAMA Oncol."},{"issue":"10","key":"10.1016\/j.plabm.2024.e00410_bib29","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1158\/1078-0432.CCR-20-4367","article-title":"Comprehensive molecular characterization and response to therapy in fumarate hydratase-deficient renal cell carcinoma","volume":"27","author":"Gleeson","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.plabm.2024.e00410_bib30","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ajhg.2013.04.012","article-title":"Germline BAP1 mutations predispose to renal cell carcinomas","volume":"92","author":"Popova","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.plabm.2024.e00410_bib31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/jmedgenet-2014-102912","article-title":"A germline mutation in PBRM1 predisposes to renal cell carcinoma","volume":"52","author":"Benusiglio","year":"2015","journal-title":"J. Med. Genet."},{"issue":"6","key":"10.1016\/j.plabm.2024.e00410_bib32","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.euo.2021.09.005","article-title":"Germline variants identified in patients with early-onset renal cell carcinoma referred for germline genetic testing","volume":"4","author":"Truong","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"10.1016\/j.plabm.2024.e00410_bib33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0002-9440(10)64001-1","article-title":"CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A","volume":"158","author":"Schraml","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"7","key":"10.1016\/j.plabm.2024.e00410_bib34","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/bjc.2014.420","article-title":"Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery","volume":"111","author":"El-Mokadem","year":"2014","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.plabm.2024.e00410_bib35","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1158\/0008-5472.CAN-09-0146","article-title":"Patterns of gene expression and copy-number alterations in von-hippel lindau disease-associated and sporadic clear cell carcinoma of the kidney","volume":"69","author":"Beroukhim","year":"2009","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.plabm.2024.e00410_bib36","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41467-021-21068-9","article-title":"Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma","volume":"12","author":"Bakouny","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.plabm.2024.e00410_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15770","article-title":"MYC activation cooperates with Vhl and Ink4a\/Arf loss to induce clear cell renal cell carcinoma","volume":"8","author":"Bailey","year":"2017","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.plabm.2024.e00410_bib38","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1158\/1078-0432.CCR-17-1057","article-title":"Sarcomatoid renal cell carcinoma has a distinct molecular pathogenesis, driver mutation profile, and transcriptional landscape","volume":"23","author":"Wang","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.plabm.2024.e00410_bib39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41598-020-57534-5","article-title":"Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers","volume":"10","author":"Malouf","year":"2020","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.plabm.2024.e00410_bib40","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41379-021-00779-w","article-title":"New developments in existing WHO entities and evolving molecular concepts: the Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.plabm.2024.e00410_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.871252","article-title":"Models of renal cell carcinoma used to investigate molecular mechanisms and develop new therapeutics","volume":"12","author":"Shapiro","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.plabm.2024.e00410_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cells13010034","article-title":"Emerging immunotherapy approaches for advanced clear cell renal cell carcinoma","volume":"13","author":"Meng","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.plabm.2024.e00410_bib43","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1016\/j.juro.2009.07.049","article-title":"Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology--is up-front resection indicated and, if not, is it avoidable?","volume":"182","author":"Shuch","year":"2009","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.plabm.2024.e00410_bib44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00000478-200103000-00001","article-title":"Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases","volume":"25","author":"de Peralta-Venturina","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.plabm.2024.e00410_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-5347(05)65384-0","article-title":"Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma","volume":"167","author":"Mian","year":"2002","journal-title":"J. Urol."},{"issue":"4","key":"10.1016\/j.plabm.2024.e00410_bib46","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.eururo.2022.03.006","article-title":"European association of urology guidelines on renal cell carcinoma: the 2022 update","volume":"82","author":"Ljungberg","year":"2022","journal-title":"Eur. Urol."},{"issue":"12","key":"10.1016\/j.plabm.2024.e00410_bib47","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41585-020-00382-9","article-title":"Sarcomatoid renal cell carcinoma: biology, natural history and management","volume":"17","author":"Blum","year":"2020","journal-title":"Nat. Rev. Urol."},{"issue":"3","key":"10.1016\/j.plabm.2024.e00410_bib48","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.euo.2023.11.016","article-title":"Real-world assessment of clinical outcomes in patients with metastatic renal cell carcinoma with or without sarcomatoid features treated with first-line systemic therapies","volume":"7","author":"Sawaya","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"12","key":"10.1016\/j.plabm.2024.e00410_bib49","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/2326-6066.CIR-15-0150","article-title":"PD-1 and PD-L1 expression in renal cell carcinoma with sarcomatoid differentiation","volume":"3","author":"Joseph","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.plabm.2024.e00410_bib50","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000002233","article-title":"Sarcomatoid and rhabdoid renal cell carcinoma: clinical, pathologic, and molecular genetic features","author":"Adeniran","year":"2024","journal-title":"Am. J. Surg. Pathol."}],"container-title":["Practical Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352551724000568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352551724000568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:41:15Z","timestamp":1778877675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352551724000568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":50,"alternative-id":["S2352551724000568"],"URL":"https:\/\/doi.org\/10.1016\/j.plabm.2024.e00410","relation":{},"ISSN":["2352-5517"],"issn-type":[{"value":"2352-5517","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic study of the CDKN2A and CDKN2B genes in renal cell carcinoma patients","name":"articletitle","label":"Article Title"},{"value":"Practical Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plabm.2024.e00410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Mahidol University. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"e00410"}}